Company Filing History:
Years Active: 2007
Title: Yehudit Gerassi - Innovator in Microarray Hybridization Technology
Introduction
Yehudit Gerassi is a prominent inventor based in San Diego, CA, known for her innovative contributions to the field of biotechnology. She has developed a unique microarray hybridization device that enhances the efficiency and consistency of hybridization reactions. Her work has significant implications for molecular biology and diagnostics.
Latest Patents
Yehudit Gerassi holds 1 patent for her invention titled "Microarray hybridization device having bubble-fracturing elements." This novel device improves the efficiency of microarray hybridization reactions by achieving a greater degree of internal mixing of the target solution. The device features a gasket-and-cover-type chamber where solution mixing is facilitated by the creation of numerous microbubbles. The inner walls of the chamber contain bubble-rupturing elements that extend into the chamber and terminate in sharp edges. These elements are strategically positioned to break larger bubbles into microbubbles, enhancing solution mixing and ensuring a uniform distribution of target molecules to the probe molecules bound to the substrate. This innovation significantly increases the sensitivity and consistency of hybridization reactions.
Career Highlights
Yehudit Gerassi is currently associated with Biocept, Inc., where she continues to advance her research and development efforts. Her work at Biocept focuses on improving diagnostic technologies through innovative solutions in molecular biology.
Collaborations
Yehudit collaborates with talented professionals in her field, including Soonkap Hahn and Jhobe Steadman. These collaborations foster a dynamic environment for innovation and development in biotechnology.
Conclusion
Yehudit Gerassi's contributions to microarray hybridization technology exemplify her commitment to advancing the field of biotechnology. Her innovative device not only enhances the efficiency of hybridization reactions but also sets a new standard for sensitivity and consistency in molecular diagnostics.